Page 19 - Eua News Today

The expert panel of the central drug regulator has recommended that Bharat Biotech's Covaxin be given marketing authorization with conditions for restricted emergency use (EUA) in children and adolescents aged two to eighteen years. But, top government sources stated on Tuesday that the ultimate approval of EUA from the drug authority and inclusion of the vaccine in the

Ethics sitting in sacramento to say he knows whats best for my body and even though im a physician, ive decided for my body, from my certain risk situation, i dont want it. now hes saying i know its best for you and you have to take it. i told my administration that this violates the nuremberg code. there is no fully approved vaccine available in the united states and so this is still under eua if you read page two of the memo from the fda this is the pfizer vaccine is still under eua and you ar...

Results. about a third said yes right away. about a third said im going to wait and see. a quarter said definitely not. and is then a small number said only if required. so thats not a fabulous place to start with 1 out of 4 saying definitely not. but i guess its a place to start. and thats where the mandates might come in. >> in terms of the mandates, now were really starting to now that the eua submission is in is where its being floated as to whether a coronavirus vaccine could be added to th...

>> it really will be interesting to see what happens with this 5 to 11-year-old group if pfizer does get an eua later this month for their covid-19 vaccine. lets take a look at how its been going for 12 to 17-year-olds. this group got emergency use authorization back in the spring, becoack in may. so youd think people would want to protect their children. but look at this map. you have all of these states, alabama, georgia, louisiana, all throughout parts of the south, north dakota, wyoming, les...

Relief. >> yeah, i think we are right there with you. a huge relief when my 14-year-old did and i got home from d.c. last night and my 11-year-old said to me, mom, do you have any news on pfizer, did they ask for an eua? clearly we talk about it a lot. he did say eua. when we look at this, we know we have this timeline for the advisers for when theyre supposed to meet. could the fact that theyre officially asking for this eua now, could that in any way change the timeline? >> i think that now th...

"washington post." you say, number one, shots for younger kids. this could be sooner rather than later, which, of course, is good news. in learning this, do you think changes could come? could this official request for an eua, could that change the time line at all? >> i really hope not because the fda has already said that theyre approached authorization for the vaccines for 5 to 11-year-olds with urgency. this is the reason why they already set an advisory committee meeting for october 26th, p...

New this morning, astrazeneca is asking the fda for emergency use authorization for its antibody therapy meant to prevent symptomatic covid-19. this as johnson & johnson seeking eua for a booster dose of its one shot vaccine. >> joining us now to talk through this, dr. carlos del rio, executive associate dean of emory university school of medicine at grady health system. always good to see you. lets start with this j&j request for an eua for a booster shot to its one dose vaccine. there has been...

In conversation with Dr Sabyasachi Chatterjee, president of the All India People's Science Network.

Very exciting. thats a different committee that meets. thats not the vaccine committee, and obviously a very important story, a very busy month of october, and i think americans can be happy and welcome the news that fda is on it, and all of these interventions may be poised to benefit us. but we doent want to pre-judge the data. safety comes first. safety and efficacy are the two tasks we take first. >> of course there are steps between the submission of the data for pfizer for children under 1...

Patients. theyll request emergency use authorization from the fda as soon as possible. earlier this evening, i spoke with dr. jonathan reiner, a cnn medical analyst. >> unlike monoclonal antibodies which are always effective, this drug is orally available, so well be able to prescribe this to folks. theyll take a five-day course and hopefully be able to stay homes not come in for an intravenous infusion and keep folks out of the hospital. its really very promising news. merck has promised the un...